| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.0074 | 0.8 |